Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7

Get the latest international news and world events from around the world.

Log in for authorized contributors

New Discovery: This Molecule Could Beat Rapamycin in Longevity

Get Our Newsletter (It’s Free): https://www.optispan.life/

Dive into the future of longevity research with Dr. Ben Blue, CEO of Ora Biomedical. We explore how Ora’s high-throughput “Wormbot” platform is conducting the world’s largest unbiased search for longevity interventions, moving beyond the narrow focus on established pathways like mTOR.

In this episode, we discuss:
• The ambitious Million Molecule Challenge and why it could revolutionize the field.
• Surprising discoveries already made, including molecules that outperform rapamycin.
• Ora’s strategic pivot to radiation resistance, with applications for astronauts, pilots, and human health.
• How their data-driven approach is uncovering interventions for resilience against toxins and other stresses.
• The journey from worm models to potential clinical trials and what’s next for the company.

Learn how Ora is scaling drug discovery to tackle aging and age-related diseases.

Home


https://twitter.com/OraBiomedical.
https://www.linkedin.com/company/ora-biomedical-inc/

This video was produced by One Billion Media, an agency that specializes in YouTube virality for health brands and experts. Learn more about their work here:

Continue reading “New Discovery: This Molecule Could Beat Rapamycin in Longevity” | >

New ‘DNA cassette tape’ can store up to 1.5 million times more data than a smartphone — and the data can last 20,000 years if frozen

Scientists have discovered that over half a mile of DNA could hold over 360,000 terabytes of data.

Caltech Team Sets Record with 6,100-Qubit Array

Quantum computers will need large numbers of qubits to tackle challenging problems in physics, chemistry, and beyond. Unlike classical bits, qubits can exist in two states at once—a phenomenon called superposition. This quirk of quantum physics gives quantum computers the potential to perform certain complex calculations better than their classical counterparts, but it also means the qubits are fragile. To compensate, researchers are building quantum computers with extra, redundant qubits to correct any errors. That is why robust quantum computers will require hundreds of thousands of qubits.

Now, in a step toward this vision, Caltech physicists have created the largest qubit array ever assembled: 6,100 neutral-atom qubits trapped in a grid by lasers. Previous arrays of this kind contained only hundreds of qubits.

This milestone comes amid a rapidly growing race to scale up quantum computers. There are several approaches in development, including those based on superconducting circuits, trapped ions, and neutral atoms, as used in the new study.

The neutral-atom platform shows promise for scaling up quantum computers.

Can you steam away prostate cancer?

Heat is one therapy to help damage and kill cancer cells, according to the National Cancer Institute. Steam offers a targeted way to deliver heat into the body, according to Abreu.

Before the procedure, physicians use magnetic resonance imaging (MRI) to locate the tumor cells in the patient’s prostate. During the procedure, doctors use an ultrasound and prostate mapping to guide a thin catheter through the patient’s urethra and into the area of the prostate where the tumor is located.

Once the catheter is positioned, a fine needle is deployed in the tumor. Doctors then release a quick, targeted 10-second burst of steam from the needle, and more bursts as needed, to destroy the tumor.

‘This procedure is thought to be much gentler on the body than traditional therapies and is designed to target the cancerous tissue within the prostate,’ said Abreu. ‘We are exploring if steam may be effective at destroying cancer cells without damaging the surrounding organs.’

B-roll video available for download below.

A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer’s Disease

Alzheimer’s disease (AD) is a neurodegenerative disease marked by the accumulation of toxic amyloid-beta (Aβ) oligomers. These oligomers are thought to cause synaptic dysfunction and contribute to neurodegeneration. CT1812 is a small-molecule sigma-2 receptor antagonist that is currently being investigated and tested as a potential disease-modifying treatment for AD. CT1812 acts by displacing Aβ oligomers into the cerebrospinal fluid and preventing their interaction with receptors on neurons. Preclinical studies and early clinical trials of CT1812 show promising results and provide evidence for its potential to slow AD progression. This review outlines the role of Aβ oligomers in AD, CT1812’s mechanism of action, and the effectiveness and limitations of CT1812 based on preclinical and clinical studies.

Feeling happier starts with kindness: Compassion tied to higher life satisfaction

People who treat others with compassion often feel more at ease themselves. This is the key finding of a new study by Majlinda Zhuniq, Dr. Friedericke Winter, and Professor Corina Aguilar-Raab from the University of Mannheim. Their study was recently published in the journal Scientific Reports.

While the link between self-compassion and well-being is well established, this effect has hardly been researched with respect to compassion for others. In a meta-analysis, the research team analyzed data from more than 40 individual studies.

The results showed that people who empathize with others, support them, or want to help them report greater overall life satisfaction, experience more joy, and see more meaning in life. On average, these people’s psychological well-being was higher. The link between compassion and a reduction in negative feelings, such as stress or sadness, was weaker. However, slight positive trends could also be seen in this respect.

Comet 3I/ATLAS displays greenish hue in new Gemini North telescope images

Gemini North captured new images of Comet 3I/ATLAS after it reemerged from behind the sun on its path out of the solar system. The data were collected during a Shadow the Scientists session—a unique outreach initiative that invites students around the world to join researchers as they observe the universe on the world’s most advanced telescopes.

On 26 November 2025, scientists used the Gemini Multi-Object Spectrograph (GMOS) on Gemini North at Maunakea in Hawai’i to obtain images of the third-ever detected interstellar object, Comet 3I/ATLAS. The new observations reveal how the comet has changed after making its closest approach to the sun. Gemini North is one half of the International Gemini Observatory and operated by NOIRLab.

After emerging from behind the sun, 3I/ATLAS reappeared in the sky close to Zaniah, a triple-star system located in the constellation Virgo. These observations were taken as part of a public outreach initiative organized by NOIRLab in collaboration with Shadow the Scientists, an initiative created to connect the public with scientists to engage in authentic scientific experiments, such as astronomy observing experiences on world-class telescopes. The scientific program was led by Bryce Bolin, a research scientist from Eureka Scientific.

/* */